Therapeutic drug monitoring of cyclosporine and tacrolimus
Open Access
- 1 July 1998
- journal article
- review article
- Published by Elsevier BV in Clinical Biochemistry
- Vol. 31 (5), 309-316
- https://doi.org/10.1016/s0009-9120(98)00049-6
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- EFFICACY OF TACROLIMUS AS RESCUE THERAPY FOR CHRONIC REJECTION IN ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1997
- KIDNEY FUNCTION AFTER 1:1 CONVERSION TO THE CYCLOSPORINE MICROEMULSION FORMULATION IN CHILDREN WITH LIVER ALLOGRAFTSTransplantation, 1997
- Evaluation of the Pro- Trac Tacrolimus Monoclonal Whole-Blood Enzyme-Linked Immunosorbent Assay for Monitoring of Tacrolimus Levels in Patients After Kidney, Heart, and Liver TransplantationTherapeutic Drug Monitoring, 1996
- Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus PanelTherapeutic Drug Monitoring, 1995
- Receptor (Immunophilin-Bhiding) Assay for Immunosuppressive DrugsTherapeutic Drug Monitoring, 1995
- Consensus Document: Therapeutic Monitoring of Tacrolimus (FK-506)Therapeutic Drug Monitoring, 1995
- Pharmacokinetics of a New Oral Formulation of Cyclosporine in Liver Transplant RecipientsTherapeutic Drug Monitoring, 1995
- CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTSTransplantation, 1995
- Interaction of Tacrolimus (FK506) and Its Metabolites with FKBP and CalcineurinBiochemical and Biophysical Research Communications, 1994
- PHARMACOKINETICS AND TOLERABILITY OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS—A CONCENTRATION-CONTROLLED COMPARISON WITH THE COMMERCIAL FORMULATIONTransplantation, 1994